Subthalamic Nucleus Deep Brain Stimulation in Early Stage Parkinson’s Disease Reduces the Risk of Polypharmacy: Five-Year Analysis
Objective: To compare the proportion of subjects on polypharmacy after five years in the deep brain stimulation (DBS) in early stage Parkinson’s disease (PD) pilot…Globus Pallidus and Pedunculopontine Nucleus Oscillations during Executed and Imagined Gait in Patient with Parkinson’s Disease and Freezing of Gait Symptoms.
Objective: To explore neurophysiological markers of intentional executed and imagined movement in both Globus Pallidus Internus (Gpi) and Pedunculopontine Nucleus (PPN) in patients with Parkinson’s…Riding the puzzle: deep brain stimulation and the non-motor symptoms in Parkinson’s disease
Objective: To better understand the benefits of DBS in non-motor symptoms. Background: Parkinson's disease(PD) is a neurodegenerative disease characterized by the loss of dopaminergic neurons,…A case of idiopathic adult-onset truncal extension dystonia treated with bilateral pallidal deep brain stimulation
Objective: To describe the outcome of deep brain stimulation (DBS) to the globus pallidus interna (GPi) in an adult patient with idiopathic truncal dystonia with…Evaluating Use of the DBS Patient Programmer
Objective: To characterize use of the Medtronic® DBS patient programmer among patients with DBS for movement disorders. Background: Patients who undergo deep brain stimulation receive…Contact location and non-motor outcomes in subthalamic nucleus deep brain stimulation for Parkinson’s disease
Objective: To determine whether the precise location of stimulation affects cognitive performance and mood. Background: Deep brain stimulation of the subthalamic nucleus effectively treats the…Postoperative delirium after deep brain stimulation surgery for Parkinson’s disease
Objective: To investigate the potential predictive factors of postoperative delirium after deep brain stimulation surgery for Parkinson’s disease (PD). Background: Subthalamic nucleus deep brain stimulation…Combined Surgical Therapies for Optimal Management of Advanced Parkinson’s Disease
Objective: We report a case of a patient with advanced PD who began LCIG for refractory motor fluctuations while continuing longstanding STN-DBS. Background: LCIG and…Assessment of new technology in deep brain stimulation technology: what are the anticipated benefits?
Objective: To assess the ability of directional DBS leads and stimulation field shaping to provide more precisely targeted therapy. Background: Deep brain stimulation (DBS) has…Interest in Genetic Testing in Parkinson’s disease patients with DBS
Objective: To determine interest in genetic testing among Parkinson’s disease (PD) patients with deep brain stimulation (DBS). Background: Nearly 27% of patients with early-onset PD…
- « Previous Page
- 1
- …
- 122
- 123
- 124
- 125
- 126
- …
- 152
- Next Page »